Education
About Us
Working with TipRanks
Follow Us
Gossamer Bio Inc (GOSS)
NASDAQ:GOSS
Total Valuation
Gossamer Bio has a market cap or net worth of $184.71M. The enterprise value is $113.35M.
Market Cap$184.71M
Enterprise Value$113.35M
Share Statistics
Gossamer Bio has 227.22M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding227.22M
Owned by Insiders9.39%
Owned by Instutions0.02%
Financial Efficiency
Gossamer Bio’s return on equity (ROE) is -1.92 and return on invested capital (ROIC) is -22.45%.
Return on Equity (ROE)-191.67%
Return on Assets (ROA)-17.93%
Return on Invested Capital (ROIC)-22.45%
Return on Capital Employed (ROCE)-22.17%
Revenue Per Employee$796,534.722
Profits Per Employee-$392,555.556
Employee Count144
Asset Turnover0.36
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Gossamer Bio is -3.62. Gossamer Bio’s PEG ratio is 0.05.
PE Ratio-3.62
PS Ratio1.78
PB Ratio6.94
Price to Fair Value6.94
Price to FCF-59.01
Price to Operating Cash Flow-59.01
PEG Ratio0.05
Income Statement
In the last 12 months, Gossamer Bio had revenue of $114.70M and earned -$56.53M in profits. Earnings per share was -$0.26.
Revenue$114.70M
Gross Profit$112.72M
Operating Income-$59.92M
Pretax Income-$55.63M
Net Income-$56.53M
EBITDA-44.46M
Earnings Per Share (EPS)-0.26
Cash Flow
In the last 12 months, operating cash flow was -$3.47M and capital expenditures $0.00, giving a free cash flow of -$119.82M billion.
Operating Cash Flow-$3.47M
Free Cash Flow-$119.82M
Free Cash Flow per Share-$0.53
Dividends & Yields
Gossamer Bio pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-1.69%
Earnings Yield-27.62%
Stock Price Statistics
Beta2.18
52-Week Price Change2.47%
50-Day Moving Average1.17
200-Day Moving Average0.98
Relative Strength Index (RSI)36.12
Average Volume (3m)1.58M
Important Dates
Gossamer Bio upcoming earnings date is May 13, 2025, Before Open.
Last Earnings DateMar 13, 2025
Next Earnings DateMay 13, 2025
Ex-Dividend Date―
Financial Position
Gossamer Bio as a current ratio of 6.88, with Debt / Equity ratio of 6.88
Current Ratio6.88
Quick Ratio6.88
Debt to Market Cap0.99
Net Debt to EBITDA-3.92
Interest Coverage Ratio-5.20
Taxes
In the past 12 months, Gossamer Bio has paid -$93.00K in taxes.
Income Tax-$93.00K
Effective Tax Rate-1.61%
Enterprise Valuation
Gossamer Bio EV to EBITDA ratio is -9.04, with an EV/FCF ratio of -104.23.
EV to Sales3.15
EV to EBITDA-9.04
EV to Free Cash Flow-104.23
EV to Operating Cash Flow-104.23
Balance Sheet
Gossamer Bio has $294.52M in cash and marketable securities with $202.88M in debt, giving a net cash position of -$91.64M billion.
Cash & Marketable Securities$294.52M
Total Debt$202.88M
Net Cash-$91.64M
Net Cash Per Share-$0.40
Tangible Book Value Per Share$0.13
Margins
Gross margin is 100.00%, with operating margin of -52.24%, and net profit margin of -49.28%.
Gross Margin100.00%
Operating Margin-52.24%
Pretax Margin-48.50%
Net Profit Margin-49.28%
EBITDA Margin-34.84%
EBIT Margin-38.46%
Analyst Forecast
The average price target for Gossamer Bio is $8.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$8.75
Price Target Upside954.22%
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast
EPS Growth Forecast81.94%